HEALEY ALS Platform Trial Weekly Q&A: December 1, 2022
Sabrina Paganoni, MD, PhD, presented this week’s updates on the HEALEY ALS Platform Trial and answered questions from the audience. We were joined by guest speaker Catherine Douthwright, PhD, Neuromuscular Clinical Research Program Director at UMass Chan Medical School in Worcester, to hear about her experience working on the Platform Trial. Visit the Mass General website to register for future webinars: https://www.massgeneral.org/neurology....